How should the lower limit of the normal range be defined?

Respiratory Care

Volumn 57, Issue 1, 2012, Pages 136-145

  Culver, Bruce H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Lung diseases; Lung function testing; Lung volume measurement; Obstructive; Outcome assessment; Reference equations; Spirometry

Indexed keywords

AGE; ARTICLE; BODY HEIGHT; BODY SIZE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; NORMAL VALUE; PROBABILITY; REFERENCE VALUE; SPIROMETRY; UNCERTAINTY;

HUMANS; LUNG VOLUME MEASUREMENTS; NUTRITION SURVEYS; PULMONARY DIFFUSING CAPACITY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; RISK ASSESSMENT; SPIROMETRY;

EID: 84856792062     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01427     Document Type: Article

References (31)

1. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144(5):1202-1218.
2. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-968.
3. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123(6):659-664.
4. Clausen JL. Prediction of normal values. in Clausen JL, editor. Pulmonary function testing: guidelines and controversies. New York: Academic Press; 1980.
5. Bates DV, Macklem PT, Christie RV. Respiratory function in disease, 2nd edition. Philadelphia: Saunders; 1971.
6. 1 to FVC. Am Rev Respir Dis 1973;108(4):1000-1003.
7. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999;159(1):179-187.
8. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-555.
9. Pistelli F, Bottai M, Viegi G, et al. Smooth reference equations for slow vital capacity and flow-volume curve indexes. Am J Respir Crit Care Med 2000;161(3 Pt 1):899-905.
10. Stanojevic S, Wade A, Stocks J, Hankinson J, Coates AL, Pan H, et al. Reference ranges for spirometry across all ages. Am J Respir Crit Care Med 2008;177(3):253-260.
11. 1/FVC ratio during childhood and adolescence: an intercontinental study. Eur Respir J 2010;36(6):1391-1399.
12. Quanjer PH, Stocks J, Cole TJ. Hall GL, Stanojevik S, Influence of secular trends and sample size on reference equations for lung function tests Eur Respir J 2011;37(3):658-664.
13. Stanojevic S, Wade A, Cole TJ, Lum S, Custovic A, Silverman M, Hall GL, et al; Asthma UK Spirometry Collaborative Group. Spirometry centile charts for young Caucasian children: The Asthma UK Collaborative Initiative. Am J Respir Crit Care Med 2009;180(6):547-552.
14. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127(6):725-734.
15. Glindmeyer HW, Lefante JJ, McColloster C, Jones RN, Weill H. Blue-collar normative spirometric values for Caucasian and African-American men and women aged 18 to 65. Am J Respir Crit Care Med 1995;151(2 Pt 1):412-422.
16. Poirier KP. A quantitative definition of obstructive lung disease (editorial). Am J Med 1968;45(3):329-335.
17. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995;152(3):1107-1136.
18. Mannino DM, Buist AS, Petty TL, Enright P, Redd SC. Lung function and mortality in the United States: data from the first National Health and Nutrition Examination Survey follow up study. Thorax 2003;58(5):388-393.
19. Mannino DM, Buist AS, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 2007;62(3):237-241.
20. 1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181(5):446-451.
21. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurement. Official Statement of the ERS. Eur Respir J 1995;8(3):492-506.
22. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yemault JC. Lung volumes and ventilatory flows. Report Working Party Standardization of Lung Function Tests. European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993;6(Suppl):5-40.
23. Crapo RO, Morris AH, Clayton PD, Nixon CR. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 1982;18(3):419-425.
24. Goldman HI, Becklake MR. Respiratory function tests: normal values at median altitudes and the prediction of normal results. Am Rev Tuberc 1959;79(4):457-467.
25. Roca J, Burgos F, Barbera J, Sunyer J, Rodriguez-Roisin R, Castellsague J, et al. Prediction equations for plethysmographic lung volumes. Respir Med 1998;92(3):454-460.
26. Marsh S, Aldington S, Williams M, Weatherall M, Shirtcliffe P, McNaughton A, et al. Complete reference ranges for pulmonary function tests from a single New Zealand population. N Z Med J 2006;119(1244):U2281. Erratum in: N Z Med J 2007;120(1254): U2551.
27. Jensen R. Personal communication.
28. LCO instruments in global clinical trials. Eur Respir J 2009;33(4):828-834.
29. Culver BH. Preoperative management of the thoracic surgery patient: pulmonary function testing. Semin Thorac Cardiovasc Surg 2001;13(2):92-104.
30. Ferguson MK, Vigneswaran WT. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg 2008;85(4):1158-1164.
31. Vedal S, Crapo RO. False positive rates of multiple pulmonary function tests in healthy subjects. Bull Eur Physiopathol Respir 1983;19(3):263-266.